{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:06:46Z","timestamp":1793286406566,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000971","name":"Diabetes Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000971","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["GNT1079645"],"award-info":[{"award-number":["GNT1079645"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baker Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epidemiologic data suggest that the prevalence of hypertension in patients with diabetes mellitus is \u223c1.5\u20132.0 times greater than in matched non-diabetic patients. This co-existent disease burden exacerbates cardiac and vascular injury, leading to structural and functional changes to the myocardium, impaired cardiac function and heart failure. Oxidative stress and persistent low-grade inflammation underlie both conditions, and are identified as major contributors to pathological cardiac remodelling. There is an urgent need for effective therapies that specifically target oxidative stress and inflammation to protect against cardiac remodelling. Animal models are a valuable tool for testing emerging therapeutics, however, there is a notable lack of appropriate animal models of co-morbid diabetes and hypertension. In this study, we describe a novel preclinical mouse model combining diabetes and hypertension to investigate cardiac and vascular pathology of co-morbid disease. Type 1 diabetes was induced in spontaneously hypertensive, 8-week old, male Schlager (BPH\/2) mice via 5 consecutive, daily injections of streptozotocin (55\u00a0mg\/kg in citrate buffer; i.p.). Non-diabetic mice received citrate buffer only. After 10\u00a0weeks of diabetes induction, cardiac function was assessed by echocardiography prior to post-mortem evaluation of cardiomyocyte hypertrophy, interstitial fibrosis and inflammation by histology, RT-PCR and flow cytometry. We focussed on the oxidative and inflammatory stress pathways that contribute to cardiovascular remodelling. In particular, we demonstrate that markers of inflammation (monocyte chemoattractant protein; MCP-1), oxidative stress (urinary 8-isoprostanes) and fibrosis (connective tissue growth factor; CTGF) are significantly increased, whilst diastolic dysfunction, as indicated by prolonged isovolumic relaxation time (IVRT), is elevated in this diabetic and hypertensive mouse model. In summary, this pre-clinical mouse model provides researchers with a tool to test therapeutic strategies unique to co-morbid diabetes and hypertension, thereby facilitating the emergence of novel therapeutics to combat the cardiovascular consequences of these debilitating co-morbidities.<\/jats:p>","DOI":"10.1038\/s41598-023-35680-w","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:04:41Z","timestamp":1685437481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities"],"prefix":"10.1038","volume":"13","author":[{"given":"Arpeeta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy S. Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M. D.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man K. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"De Blasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy B.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"issue":"5","key":"35680_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie, J. R., Guzik, T. J. & Touyz, R. M. Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Can. J. Cardiol. 34(5), 575\u2013584 (2018).","journal-title":"Can. J. Cardiol."},{"key":"35680_CR2","doi-asserted-by":"publisher","first-page":"653789","DOI":"10.1155\/2013\/653789","volume":"2013","author":"AS Matheus","year":"2013","unstructured":"Matheus, A. S. et al. Impact of diabetes on cardiovascular disease: An update. Int. J. Hypertens 2013, 653789 (2013).","journal-title":"Int. J. Hypertens"},{"issue":"2","key":"35680_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88\u201398 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"35680_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2020.00124","volume":"11","author":"MJ De Blasio","year":"2020","unstructured":"De Blasio, M. J. et al. Defining the progression of diabetic cardiomyopathy in a mouse model of type 1 diabetes. Front. Physiol. 11, 124 (2020).","journal-title":"Front. Physiol."},{"issue":"11","key":"35680_CR5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie, R. H. & Abel, E. D. Basic mechanisms of diabetic heart disease. Circ. Res. 126(11), 1501\u20131525 (2020).","journal-title":"Circ. Res."},{"issue":"8","key":"35680_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/heartjnl-2012-302029","volume":"99","author":"NP Chokshi","year":"2013","unstructured":"Chokshi, N. P., Grossman, E. & Messerli, F. H. Blood pressure and diabetes: Vicious twins. Heart 99(8), 577\u2013585 (2013).","journal-title":"Heart"},{"issue":"11","key":"35680_CR7","first-page":"1277","volume":"78","author":"KL Whalen","year":"2008","unstructured":"Whalen, K. L. & Stewart, R. D. Pharmacologic management of hypertension in patients with diabetes. Am. Fam. Physician. 78(11), 1277\u20131282 (2008).","journal-title":"Am. Fam. Physician."},{"issue":"2","key":"35680_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino, F. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 41(2), 255\u2013323 (2020).","journal-title":"Eur. Heart J."},{"issue":"6","key":"35680_CR9","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6), e13\u2013e115 (2018).","journal-title":"Hypertension"},{"issue":"1","key":"35680_CR10","doi-asserted-by":"publisher","first-page":"H176","DOI":"10.1152\/ajpheart.00058.2022","volume":"323","author":"LC Heather","year":"2022","unstructured":"Heather, L. C. et al. Guidelines on models of diabetic heart disease. Am. J. Physiol. Heart Circ. Physiol. 323(1), H176\u2013H200 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"35680_CR11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.tips.2022.04.005","volume":"43","author":"D Prakoso","year":"2022","unstructured":"Prakoso, D. et al. Current landscape of preclinical models of diabetic cardiomyopathy. Trends Pharmacol. Sci. 43(11), 940\u2013956 (2022).","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"35680_CR12","doi-asserted-by":"publisher","first-page":"H670","DOI":"10.1152\/ajpheart.00922.2013","volume":"307","author":"MT Kuroki","year":"2014","unstructured":"Kuroki, M. T., Fink, G. D. & Osborn, J. W. Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration. Am. J. Physiol. Heart Circ. Physiol. 307(5), H670\u2013H679 (2014).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"35680_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fphys.2014.00396","volume":"5","author":"JR Gomolak","year":"2014","unstructured":"Gomolak, J. R. & Didion, S. P. Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation. Front. Physiol. 5, 396 (2014).","journal-title":"Front. Physiol."},{"issue":"47","key":"35680_CR14","doi-asserted-by":"publisher","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"SD Crowley","year":"2006","unstructured":"Crowley, S. D. et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. USA 103(47), 17985\u201317990 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"35680_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0026-0495(91)90141-I","volume":"40","author":"GM Reaven","year":"1991","unstructured":"Reaven, G. M. & Ho, H. Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 40(4), 335\u2013337 (1991).","journal-title":"Metabolism"},{"issue":"1\u20132","key":"35680_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10641969909068644","volume":"21","author":"PA van Zwieten","year":"1999","unstructured":"van Zwieten, P. A. Diabetes and hypertension: Experimental models for pharmacological studies. Clin. Exp. Hypertens 21(1\u20132), 1\u201316 (1999).","journal-title":"Clin. Exp. Hypertens"},{"issue":"4","key":"35680_CR17","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","volume":"97","author":"YT Zhou","year":"2000","unstructured":"Zhou, Y. T. et al. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc. Natl. Acad. Sci. USA 97(4), 1784\u20131789 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"35680_CR18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3390\/ijms21062035","volume":"21","author":"I Martinelli","year":"2020","unstructured":"Martinelli, I. et al. Cardiovascular changes related to metabolic syndrome: Evidence in obese Zucker rats. Int. J. Mol. Sci. 21(6), 2035 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"35680_CR19","doi-asserted-by":"publisher","first-page":"R727","DOI":"10.1152\/ajpregu.00382.2012","volume":"305","author":"TN Slaughter","year":"2013","unstructured":"Slaughter, T. N. et al. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305(7), R727\u2013R734 (2013).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"7","key":"35680_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/eurjhf\/hfp070","volume":"11","author":"JM Nielsen","year":"2009","unstructured":"Nielsen, J. M. et al. Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db\/db type 2 diabetic mice. Eur. J. Heart Fail 11(7), 638\u2013647 (2009).","journal-title":"Eur. J. Heart Fail"},{"issue":"2","key":"35680_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.108.124776","volume":"53","author":"AC Goncalves","year":"2009","unstructured":"Goncalves, A. C. et al. Diabetic hypertensive leptin receptor-deficient db\/db mice develop cardioregulatory autonomic dysfunction. Hypertension 53(2), 387\u2013392 (2009).","journal-title":"Hypertension"},{"key":"35680_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2840-7-7","volume":"7","author":"MF Shehata","year":"2008","unstructured":"Shehata, M. F. Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats. Cardiovasc. Diabetol. 7, 7 (2008).","journal-title":"Cardiovasc. Diabetol."},{"key":"35680_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fphys.2019.01311","volume":"10","author":"KL Jackson","year":"2019","unstructured":"Jackson, K. L. et al. Mechanisms responsible for genetic hypertension in schlager BPH\/2 mice. Front. Physiol. 10, 1311 (2019).","journal-title":"Front. Physiol."},{"issue":"3","key":"35680_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/genetics\/76.3.537","volume":"76","author":"G Schlager","year":"1974","unstructured":"Schlager, G. Selection for blood pressure levels in mice. Genetics 76(3), 537\u2013549 (1974).","journal-title":"Genetics"},{"issue":"3","key":"35680_CR25","first-page":"288","volume":"47","author":"G Schlager","year":"1997","unstructured":"Schlager, G. & Sides, J. Characterization of hypertensive and hypotensive inbred strains of mice. Lab. Anim. Sci. 47(3), 288\u2013292 (1997).","journal-title":"Lab. Anim. Sci."},{"key":"35680_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fphys.2019.00309","volume":"10","author":"AMD Watson","year":"2019","unstructured":"Watson, A. M. D. et al. Diabetes and hypertension differentially affect renal catecholamines and renal reactive oxygen species. Front. Physiol. 10, 309 (2019).","journal-title":"Front. Physiol."},{"key":"35680_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","volume":"244","author":"SN Goyal","year":"2016","unstructured":"Goyal, S. N. et al. Challenges and issues with streptozotocin-induced diabetes: A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem. Biol. Interact. 244, 49\u201363 (2016).","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"35680_CR28","doi-asserted-by":"publisher","first-page":"H58","DOI":"10.1152\/ajpheart.00157.2018","volume":"315","author":"DG Donner","year":"2018","unstructured":"Donner, D. G. et al. Improving the quality of preclinical research echocardiography: Observations, training, and guidelines for measurement. Am. J. Physiol. Heart Circ. Physiol. 315(1), H58\u2013H70 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"35680_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2337\/db20-0357","volume":"70","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis. Diabetes 70(3), 772\u2013787 (2021).","journal-title":"Diabetes"},{"issue":"11","key":"35680_CR30","doi-asserted-by":"publisher","first-page":"e1206","DOI":"10.1002\/cti2.1206","volume":"9","author":"D Dragoljevic","year":"2020","unstructured":"Dragoljevic, D. et al. Inhibition of interleukin-1beta signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis. Clin. Transl. Immunol. 9(11), e1206 (2020).","journal-title":"Clin. Transl. Immunol."},{"issue":"2","key":"35680_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1399-543X.2005.00110.x","volume":"6","author":"EF Roche","year":"2005","unstructured":"Roche, E. F. et al. Clinical presentation of type 1 diabetes. Pediatr. Diabetes 6(2), 75\u201378 (2005).","journal-title":"Pediatr. Diabetes"},{"issue":"8","key":"35680_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","volume":"48","author":"M Galderisi","year":"2006","unstructured":"Galderisi, M. Diastolic dysfunction and diabetic cardiomyopathy: Evaluation by Doppler echocardiography. J. Am. Coll. Cardiol. 48(8), 1548\u20131551 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1 Pt 2","key":"35680_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcmg.2018.10.038","volume":"13","author":"SF Nagueh","year":"2020","unstructured":"Nagueh, S. F. Left ventricular diastolic function: Understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC Cardiovasc. Imaging 13(1 Pt 2), 228\u2013244 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"35680_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2017.10.006","volume":"114","author":"M Schnelle","year":"2018","unstructured":"Schnelle, M. et al. Echocardiographic evaluation of diastolic function in mouse models of heart disease. J. Mol. Cell. Cardiol. 114, 20\u201328 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"35680_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.amjcard.2005.07.116","volume":"97","author":"CS Chung","year":"2006","unstructured":"Chung, C. S. & Kovacs, S. J. Consequences of increasing heart rate on deceleration time, the velocity-time integral, and E\/A. Am. J. Cardiol. 97(1), 130\u2013136 (2006).","journal-title":"Am. J. Cardiol."},{"issue":"9841","key":"35680_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","volume":"380","author":"E Ferrannini","year":"2012","unstructured":"Ferrannini, E. & Cushman, W. C. Diabetes and hypertension: The bad companions. Lancet 380(9841), 601\u2013610 (2012).","journal-title":"Lancet"},{"issue":"4","key":"35680_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati, G. et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc. Res. 113(4), 378\u2013388 (2017).","journal-title":"Cardiovasc. Res."},{"key":"35680_CR38","first-page":"202","volume":"129","author":"SD Prabhu","year":"2018","unstructured":"Prabhu, S. D. The cardiosplenic axis is essential for the pathogenesis of ischemic heart failure. Trans. Am. Clin. Climatol. Assoc. 129, 202\u2013214 (2018).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"2","key":"35680_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.113.301720","volume":"114","author":"MA Ismahil","year":"2014","unstructured":"Ismahil, M. A. et al. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: Critical importance of the cardiosplenic axis. Circ. Res. 114(2), 266\u2013282 (2014).","journal-title":"Circ. Res."},{"issue":"12","key":"35680_CR40","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204(12), 3037\u20133047 (2007).","journal-title":"J. Exp. Med."},{"issue":"1","key":"35680_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20111009","volume":"209","author":"F Leuschner","year":"2012","unstructured":"Leuschner, F. et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209(1), 123\u2013137 (2012).","journal-title":"J. Exp. Med."},{"issue":"3","key":"35680_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/path.5370","volume":"250","author":"YP Jarajapu","year":"2020","unstructured":"Jarajapu, Y. P. Diabetic pre-programming of myelopoiesis impairs tissue repair. J. Pathol. 250(3), 245\u2013247 (2020).","journal-title":"J. Pathol."},{"issue":"1","key":"35680_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nyas.13462","volume":"1402","author":"TJ Barrett","year":"2017","unstructured":"Barrett, T. J. et al. Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk. Ann. N. Y. Acad. Sci. 1402(1), 31\u201342 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"35680_CR44","doi-asserted-by":"publisher","first-page":"e0238727","DOI":"10.1371\/journal.pone.0238727","volume":"15","author":"A Saadane","year":"2020","unstructured":"Saadane, A. et al. Successful induction of diabetes in mice demonstrates no gender difference in development of early diabetic retinopathy. PLoS ONE 15(9), e0238727 (2020).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35680-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35680-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35680-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T10:12:47Z","timestamp":1685441567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35680-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35680-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8741"}}